- Report
- August 2024
- 80 Pages
Japan
From €3205EUR$3,500USD£2,729GBP
- Report
- October 2023
- 190 Pages
Global
From €4121EUR$4,500USD£3,509GBP
- Report
- October 2023
- 189 Pages
Global
From €4121EUR$4,500USD£3,509GBP
- Report
- October 2023
- 71 Pages
India
From €3205EUR$3,500USD£2,729GBP
- Report
- April 2023
- 115 Pages
Global
From €4350EUR$4,750USD£3,704GBP
- Report
- August 2022
- 111 Pages
Global
From €4350EUR$4,750USD£3,704GBP
- Report
- June 2022
- 140 Pages
Global
From €4350EUR$4,750USD£3,704GBP
- Report
- July 2021
- 116 Pages
Global
From €4350EUR$4,750USD£3,704GBP
- Report
- June 2020
- 114 Pages
Global
From €4350EUR$4,750USD£3,704GBP
- Report
- April 2023
- 120 Pages
Global
From €4350EUR$4,750USD£3,704GBP
- Report
- April 2023
- 110 Pages
Global
From €4350EUR$4,750USD£3,704GBP
- Report
- April 2023
- 117 Pages
Global
From €4350EUR$4,750USD£3,704GBP
- Report
- April 2023
- 117 Pages
Global
From €4350EUR$4,750USD£3,704GBP
- Report
- August 2022
- 118 Pages
Global
From €4350EUR$4,750USD£3,704GBP
- Report
- August 2020
- 112 Pages
Global
From €3892EUR$4,250USD£3,314GBP
- Report
- October 2023
- 181 Pages
Global
From €4121EUR$4,500USD£3,509GBP
- Report
- October 2023
- 190 Pages
Global
From €4121EUR$4,500USD£3,509GBP
- Report
- December 2022
- 116 Pages
Global
From €4121EUR$4,500USD£3,509GBP
- Report
- April 2022
- 94 Pages
Global
From €6406EUR$6,995USD£5,454GBP
- Report
- June 2021
Global
From €13733EUR$14,995USD£11,692GBP

The Immune Disorders Drugs market is composed of drugs used to treat a variety of conditions related to the immune system. These drugs are used to treat autoimmune diseases, allergies, and other conditions that affect the body's ability to fight off infection. Inflammation drugs are a subset of these drugs, used to reduce inflammation and swelling caused by an immune response. These drugs can be used to treat a variety of conditions, including rheumatoid arthritis, psoriasis, and Crohn's disease. They can also be used to reduce the risk of infection in patients with weakened immune systems.
Inflammation drugs are typically administered orally or intravenously, and can be taken as a single dose or as part of a longer-term treatment plan. Common side effects of these drugs include nausea, vomiting, and diarrhea.
Companies in the Immune Disorders Drugs market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more